Clinical trial · Interventional
Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant
Use of a Computer-Guided Glucose Management System for Patients Undergoing Blood and Marrow Transplants (BMT)
NCT01236885CI-TRIAL-00017630completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial studies computer-guided glucose management systems in treating patients with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided glucose management system may help manage glucose levels in patients who have undergone blood or bone marrow transplant.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hyperglycemia | — | UNRESOLVED | — |
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| computer-assisted intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportive care (Glucommander)
- description
- Patients receive blood glucose management with IV insulin using Glucommander.
- interventionNames
- Other: computer-assisted intervention
Primary outcomes (1)
- measure
- Percentage of glucose values within target range (100-140) by using CGGMS
- timeFrame
- Up to 2 years
- description
- Standard statistical methods for rate and proportions will be used to assess binary outcomes, and standard methods for continuous data will be used for quantitative outcomes.
Secondary outcomes (8)
- measure
- Percentage of patients who experience hypoglycemia (defined as at least one blood glucose value less than 70)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Post-transplant adult patients (age \>= 18 years) on the BMT Service at UWMC * Requiring insulin secondary to: * Known history of (h/o) type 2 diabetes mellitus * Two blood sugar values \> 180 (point of care and/or am lab glycemia) * One blood sugar value \> 250 (point of care or AM lab glycemia) Exclusion Criteria: * Critically ill patients (intensive care unit \[ICU\] admissions) * Terminally ill patients * Eastern Cooperative Oncology Group (ECOG) performance status \> 3 * Previous type 1 diabetes mellitus * Cognitively impaired patients, unable to consent
References
Publications (0)
Data not yet available
No reference posted for this study.